AAV Packaging Service

About AAV Vectors

Adeno-associated virus (AAV) is a prominent viral vector in today's clinical and biomedical studies, known for its long-term stable expression and minimal immune responses, positioning it as a top choice for animal experiments and human gene therapies.

It ensures a high level of safety, allowing for operations in Biosafety Level 1 (BSL-1) laboratories unless involving certain pathogenic gene expressions. The AAV can be paired with technologies such as shRNA, CRISPR-Cas, and miRNA, facilitating nuanced control over various genes or ncRNAs expression levels, and supports the expression of protein tools for extensive research.

Furthermore, AAV offers flexible administration methods in animal studies, including systemic intravenous injections, working in conjunction with cell-type-specific promoters to achieve precise and uniform gene expression control within designated organ tissues.

Researcher working with adeno-associated virus (AAV) in the laboratory

Services

We offer a variety of AAV packaging services.

AAV packaging scales and prices
Cat. no. Application Scale Titer
(200 ul)
Transfer plasmid
needed
Price (TWD) Turnaround
AAV pack. Plasmid prep.
AAVPS-N-1E12 Cell culture
(non-purified)
> 1 x 1012 vg > 5 x 1012 vg/ml 50 ug NT$ 10,000 NT$ 3,000 3 - 5 weeks
AAVPS-P-2E12 Cell culture,
in vivo
(purified)
> 2 x 1012 vg > 1 x 1013 vg/ml 70 ug NT$ 15,000 NT$ 3,000
AAVPS-P-5E12 > 5 x 1012 vg > 2 x 1013 vg/ml 150 ug NT$ 19,000 NT$ 4,000
AAVPS-P-1E13 > 1 x 1013 vg > 5 x 1013 vg/ml 300 ug NT$ 26,000 NT$ 5,000
-- Other scales -- Please inquire -- --

← Scroll the table sideways →

  • The volume of all scales is 200 ul.
  • If amplifying plasmids yourself, please use commercial Midi/Maxi/Mega kits for purification to maintain viral packaging quality.

Tissue Tropism

Different AAV serotypes have preferences for entering different tissues and cell types.
The tissue tropism for each serotype are listed below for reference:

Tissue tropism of each AAV serotype
Tissue AAV1 AAV2 AAV5 AAV6 AAV8 AAV9 AAV-rh10 AAV-DJ AAV-PHP.S AAV-PHP.eB AAV-BR1 AAV2-retro
CNS ✽ ✽ ✽ ✽ ✽ ✽ ✽ ✽
PNS ✽
Retina ✽ ✽ ✽ ✽ ✽ ✽ ✽
Inner ear ✽ ✽ ✽ ✽
Heart ✽ ✽ ✽ ✽ ✽ ✽ ✽ ✽
Lung ✽ ✽ ✽ ✽ ✽
Liver ✽ ✽ ✽ ✽ ✽ ✽ ✽
Kidney ✽ ✽ ✽ ✽
Pancreas ✽ ✽ ✽ ✽ ✽
Spleen ✽
Testis ✽ ✽
Adipose tissue ✽ ✽
Smooth muscle ✽ ✽ ✽ ✽ ✽
Skeletal muscle ✽ ✽
Brain endothelial cell ✽

← Scroll the table sideways →

  • AAV-PHP.eB can effectively pass through the blood-brain barrier and enter the central nervous system via intravenous injection.
  • AAV2-retro can enter cells from neuronal axons, retrogradely travel to the cell nucleus, and perform expression functions (such as expressing fluorescent proteins), making it widely used in retrograde tracing studies of neural projections.
  • AAV-DJ is an artificially modified type that combines sequences from eight natural serotypes and is commonly used in in vitro cell culture experiments.

AAV9 as an Example

The figure shows the western blot results of GAPDH protein expression in four organ tissues of 8-week-old mice, four weeks after systemic administration of 5 x 1011 vg (⬢) and 1 x 1012 vg (⬢⬢) of AAV9 carrying CAG promoter and GAPDH gene via tail vein injection. The control group (⬡⬡) was given 1 x 1012 vg of AAV9 carrying only the CAG promoter and no GAPDH gene.

⬡⬡ ⬢ ⬢⬢

Heart GAPDH protein western blot result in heart tissue
Liver GAPDH protein western blot result in liver tissue
Sk. muscle GAPDH protein western blot result in sk. muscle tissue
Pancreas GAPDH protein western blot result in pancreas tissue

Tools

Choosing an appropriate promoter can help reduce the impact on non-target cells.
The following are some tissue-specific promoters for reference (with literature links):

Tissue- and cell-specific promoters with references
Cell typePromoter
Excitatory neuronhSyn (0.5kb) / CaMKII (0.4kb)
Motor neuronHb9 (1.6kb)
Dopaminergic neuronTH (2.5kb)
Glutamatergic neuronPAG (2.4kb)
GABAergic neuronGAD65 (2.5kb)
Neuronal activityc-Fos (0.8kb) / eSARE (1kb)
AstrocyteGFAP (gfaABC1D, 0.7kb) / ALDH1L1 (1.3kb)
OligodendrocyteMBP (1.9kb) / MAG (1.5kb)
Schwann cellMpz (1.2kb)
Microglia, MacrophageF4/80 (0.7kb) / CD68 (0.8kb)
Retinal Muller cellNR2E1 (Ple264, 2kb)
Retinal pigment epitheliumNA65p (0.8kb)
Brain endothelial cellPle261 (3kb)
Endothelial cellFlt1 (1kb)
Pulmonary club cellCCSP (2.3kb)
Cardiac musclecTnT (0.7kb) / aMHC (0.4kb)
Cardiac atrial muscleNppa (0.5kb)
Cardiac ventricular muscleMyl2 (0.3kb)
Liver hepatocyteTBG (0.8kb)
Kidney podocyteNPHS1 (1.25kb)
Skeletal muscleACTA1 (2.2kb)
Pancreas beta cellRIP (0.6kb)
Pancreas acinar cellElastase I (0.3kb)
Pancreas alpha cellGCG (0.7kb)
OsteoblastCol1a1 (2.3kb)

CaMKII as an Example

The figure shows the results of eGFP expression in specific cell types in the brain of 8-week-old mice, four weeks after systemic administration of 1 x 1012 vg of AAV-PHP.eB carrying CaMKII promoter and eGFP gene via tail vein injection.

eGFP expression in mouse brain 4 weeks after AAV-PHP.eB injection

Production

Transfer Plasmid

The AAV transfer plasmid is a plasmid carrying the sequence to be packaged into the AAV. Its most significant feature is a pair of identical but oppositely oriented ITR (Inverted Terminal Repeat) sequences. The sequences between this pair of ITRs, such as the promoter and target gene sequences, will be packaged into the AAV along with the ITRs, ultimately achieving gene expression by being delivered into the cell nucleus through AAV. However, it should be noted that the total length of the ITRs themselves (145bp X 2) and the sequences between the ITRs cannot exceed 4.7kb; otherwise, they cannot be completely encapsulated in the AAV. If it is inevitable to exceed 4.7kb, the split vector approaches can be referred to for combining the two sequences in the target cells, thus breaking the 4.7kb limitation.

  • Although the ITR sequences on the transfer plasmid usually originate from the AAV2 serotype, they can be used to package into all AAV serotypes.

Process

By co-transfecting HEK293 cells with three plasmids: Transfer plasmid, RepCap plasmid (determines serotype), and Helper plasmid (assists in AAV production), the virus can be generated. The RepCap plasmid contains sequences responsible for viral replication ("Rep") and capsid assembly ("Cap"). The Cap sequence is replaced accordingly based on the desired serotype of the capsid, while the Rep sequence typically originates from wild-type AAV2 serotype. Additionally, the Helper plasmid is used to simulate the natural condition where AAV must coexist with adenovirus within the cell for replication. It carries adenoviral genes E2A, E4, and VA, which are crucial for initiating AAV production.

After cells produce the virus, the lysed cells and virus-containing culture medium are first subjected to protein precipitation and collection using polyethylene glycol (PEG), followed by iodixanol gradient centrifugation to separate AAV from other protein impurities. Then, purified AAV is extracted from a specific iodixanol concentration layer, and a 100kDa MWCO concentrator is used to replace the iodixanol solution with PBS while concentrating the virus to the desired concentration.

Purification Results

The image shows the results of the AAV solution purified by us after being subjected to SDS-PAGE, transfer, and Coomassie blue total protein staining. It displays that besides the AAV capsid proteins VP1, VP2, and VP3, there are no other noticeable protein residues.

SDS-PAGE analysis of purified adeno-associated virus (AAV)

Need a different scale, or have a question?

Get in touch and we will advise and quote based on your research needs.

Contact us